L'OREAL TO HELP DEVELOP 3D PRINTED SKIN TISSUE

摘要

L'Oreal USA has announced a partnership with 3D bioprinting company Organovo Holdings Inc.The collaboration aims to develop 3D printed skin tissue for product evaluation and other areas of advanced research.The project will marry L'Oreal's expertise in skin engineering with Organovo's proprietary NovoGen Bioprinting Platform. Guive Balooch, Global Vice President of L'Oreal's Technology Incubator, explained: "Organovo has broken new ground with 3D bioprinting. an area that complements L'Oreal's pioneering work in the research and application of reconstructed skin for the past 30 years. Our partnership with Organovo will not only bring about new advanced in vitro methods for evaluating product safety and performance, but the potential for where this new field of technology and research can take us is boundless."